This Medical Tech Company Wins FDA Award For This Prominent Device

SeaStar Medical Earns Third FDA Breakthrough Device Designation for Selective Cytopheretic Device

SeaStar Medical Earns Third FDA Breakthrough Device Designation for Selective Cytopheretic Device

SeaStar Medical, a prominent medical technology company, has recently been granted its third Breakthrough Device Designation by the Food and Drug Administration (FDA). This prestigious designation was awarded for their Selective Cytopheretic Device (SCD) des…